CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Open-market sale Director sold 5,000 shares at $8.28 ($41,400)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 15,000 shares at $8.43 ($126,450)
- 4 Option exercise Chief Executive Officer acquired 50,000 shares (option exercise)
- 4 Open-market sale Director sold 20,957 shares at $8.22 ($172,267)
- 4 Open-market sale Director sold 22,500 shares at an average $8.88 ($199,750)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 4 Option exercise Director acquired 69,099 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Executive or director change
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale
- ARS Other Annual Report to Security Holders
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Shareholder rights changed
Page 66 of 74 · 1,465 filings